Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cutera stock
Own Cutera stock in just a few minutes.
Cutera, Inc is a medical devices business based in the US. Cutera shares (CUTR) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Cutera
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Cutera. Find the stock by name or ticker symbol: CUTR. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cutera reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cutera, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Cutera. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Cutera share price
Use our graph to track the performance of CUTR stocks over time.Cutera shares at a glance
Information last updated 2021-03-03.
| 52-week range | USD$9.07 - USD$38.8 |
|---|---|
| 50-day moving average | USD$29.7812 |
| 200-day moving average | USD$22.617 |
| Wall St. target price | USD$36.75 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-2.491 |
Buy Cutera shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cutera stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Cutera under- or over-valued?
Valuing Cutera stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cutera's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cutera's PEG ratio
Cutera's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.05. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cutera's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cutera financials
| Revenue TTM | USD$147.7 million |
|---|---|
| Gross profit TTM | USD$76.1 million |
| Return on assets TTM | -10.18% |
| Return on equity TTM | -46.44% |
| Profit margin | -16.17% |
| Book value | $3.222 |
| Market capitalisation | USD$625.3 million |
TTM: trailing 12 months
Shorting Cutera shares
There are currently 574,999 Cutera shares held short by investors – that's known as Cutera's "short interest". This figure is 12.5% down from 657,276 last month.
There are a few different ways that this level of interest in shorting Cutera shares can be evaluated.
Cutera's "short interest ratio" (SIR)
Cutera's "short interest ratio" (SIR) is the quantity of Cutera shares currently shorted divided by the average quantity of Cutera shares traded daily (recently around 128062.13808463). Cutera's SIR currently stands at 4.49. In other words for every 100,000 Cutera shares traded daily on the market, roughly 4490 shares are currently held short.
However Cutera's short interest can also be evaluated against the total number of Cutera shares, or, against the total number of tradable Cutera shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cutera's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Cutera shares in existence, roughly 30 shares are currently held short) or 0.0445% of the tradable shares (for every 100,000 tradable Cutera shares, roughly 45 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cutera.
Find out more about how you can short Cutera stock.
Cutera share dividends
We're not expecting Cutera to pay a dividend over the next 12 months.
Cutera share price volatility
Over the last 12 months, Cutera's shares have ranged in value from as little as $9.07 up to $38.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cutera's is 1.571. This would suggest that Cutera's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cutera overview
Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.
Frequently asked questions
More guides on Finder
-
How to buy Hayward Holdings Inc (HAYW) stock when it goes public
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
-
How to buy Alignment Healthcare Inc (ALHC) stock when it goes public
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
-
How to buy Olink Holding AB (publ) (OLK) stock when it goes public
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
-
How to buy Procore Technologies Inc (PCOR) stock when it goes public
Everything we know about the Procore Technologies Inc IPO, plus information on how to buy in.
-
How to buy Navios South American Logistics Inc (NSAL) stock when it goes public
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
-
How to buy Lava Therapeutics (LVRX) stock when it goes public
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
-
How to buy Pop Culture Group Co Ltd (CPOP) stock when it goes public
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
-
How to buy Bukalapak (CUTR.US) stock when it goes public
Everything we know about the Bukalapak IPO, plus information on how to buy in.
-
How to buy Achilles Therapeutics plc (ACHL) stock when it goes public
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
-
How to buy SEMrush Holdings Inc (SEMR) stock when it goes public
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Ask an Expert